Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration-resistant Prostate Carcinoma”

1,116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,116 results

Testing effectiveness (Phase 2)Ended earlyNCT02607228
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer
Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Large-scale testing (Phase 3)Study completedNCT01188187
What this trial is testing

Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Achieve Life Sciences 1,022
Testing effectiveness (Phase 2)Looking for participantsNCT05766371
What this trial is testing

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
University of California, San Francisco 48
Testing effectiveness (Phase 2)Looking for participantsNCT06533644
What this trial is testing

SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syncromune, Inc. 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Testing effectiveness (Phase 2)Study completedNCT01599793
What this trial is testing

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Who this might be right for
Bone MetastasesCastrate-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Chicago 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07104643
What this trial is testing

Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

Who this might be right for
mCRPC
TYK Medicines, Inc 48
Testing effectiveness (Phase 2)Looking for participantsNCT06866938
What this trial is testing

Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Hospices Civils de Lyon 58
Early research (Phase 1)Study completedNCT05022849
What this trial is testing

JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768255
What this trial is testing

Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Who this might be right for
Abiraterone AcetateMCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye 400
Testing effectiveness (Phase 2)UnknownNCT00024414
What this trial is testing

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Theradex
Testing effectiveness (Phase 2)Study completedNCT00278993
What this trial is testing

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

Who this might be right for
Prostate Cancer
Eisai Inc. 108
Testing effectiveness (Phase 2)Study completedNCT01106352
What this trial is testing

Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Bone MetastasesCastration-Resistant Prostate Cancer
Bayer 70
Testing effectiveness (Phase 2)UnknownNCT04586543
What this trial is testing

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

Who this might be right for
Metastatic Castration-resistant Prostate CancerAdenocarcinoma of the Prostate
László Mangel 110
Testing effectiveness (Phase 2)UnknownNCT00003183
What this trial is testing

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Hope Cancer Institute, Inc. 64
Load More Results